Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 12, Décembre 2009
Anticorps monoclonaux en thérapeutique
Page(s) 1163 - 1168
Section III - Un futur en développement
DOI https://doi.org/10.1051/medsci/200925121163
Publié en ligne 15 décembre 2009
  1. LEEM Biotech et Genopole. Bioproduction 2008, état des lieux et recommandations pour l’attractivité de la France. Rapport de synthèse, 2008. [Google Scholar]
  2. Cochet O, Chartrain M. Les systèmes mammaliens de production actuels qui sont agréés. Med Sci (Paris) 2009; 25 : 1078–83. [Google Scholar]
  3. Kelley B. Very large scale monoclonal antibody purification : the case for conventional unit operations. Biotechnol Prog 2007; 23 : 995–1008. [Google Scholar]
  4. Beck A, Wagner-Rousset E, Bussat MC, et al. Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and fc-fusion proteins. Curr Pharm Biotechnol 2008; 9 : 482–501. [Google Scholar]
  5. Shinkawa T, Nakamura K, Yamane N, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003; 278 : 3466–73. [Google Scholar]
  6. Arbabi-Ghahroudi M, Tanha J, MacKenzie R. Prokaryotic expression of antibodies. Cancer Metast Rev 2005; 24 : 501–19. [Google Scholar]
  7. Harmsen MM, de Haard HJ. Properties, production and applications of camelid single chain antibodies fragments. Appl Microbiol Biotechnol 2007; 77 : 13–22. [Google Scholar]
  8. Gerngross TU. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat Biotechnol 2004; 22 : 1409–14. [Google Scholar]
  9. Ogunjimi AA, Chandler JM, Gooding CM, et al. High-level secretory expression of immunologically active intact antibody from the yeast Pichia pastoris. Biotechnol Lett 1999; 21 : 561–7. [Google Scholar]
  10. Ward M, Lin C, Victoria DC, et al. Characterization of humanized antibodies secreted by Aspergillus niger. Appl Environ Microbiol 2004; 70 : 2567–76. [Google Scholar]
  11. Jigami Y. Yeast glycobiology and its application. Biosci Biotechnol Biochem 2008; 72 : 637–48. [Google Scholar]
  12. Hamilton SR, Gerngross TU. Glycosylation engineering in yeast : the advent of fully humanized yeast. Curr Opin Biotechnol 2007; 18 : 387–92. [Google Scholar]
  13. Maras M, De Bruyn A, Vervecken W, et al. In vivo synthesis of complex N-glycans by expression of human N-acetylglucosaminyltransferase I in the filamentous fungus Trichoderma reesei. FEBS Lett 1999; 452 : 365–70. [Google Scholar]
  14. Edelman L, Margaritte C, Chaabihi H, et al. Obtaining a functional recombinant anti-rhesus (D) antibody using the baculovirus-insect cell expression system. Immunology 1997; 9 : 13–9. [Google Scholar]
  15. Altmann F, Staudacher E, Wilson IB, März L. Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J 1999; 16 : 109–23. [Google Scholar]
  16. Hsu TA, Takahashi N, Tsukamoto Y, et al. Differential N-glycan patterns of secreted and intracellular IgG produced in Trichoplusia ni cells. J Biol Chem 1997; 272 : 9062–70. [Google Scholar]
  17. Harrison RL, Jarvis DL. Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce “mammalianized” recombinant glycoproteins. Adv Virus Res 2006; 68 : 159–91. [Google Scholar]
  18. O’Connell KP, Kovaleva E, Campbell JH, et al. Production of a recombinant antibody fragment in whole insect larvae. Mol Biotechnol 2007; 36 : 44–51. [Google Scholar]
  19. Floss DM, Falkenburg D, Conrad U. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants : an overview. Transgenic Res 2007; 16 : 315–32. [Google Scholar]
  20. Gomord V, Chamberlain P, Jefferis R, et al. Biopharmaceutical production in plants : problems, solutions and opportunities. Trends Biotechnol 2005; 23 : 559–65. [Google Scholar]
  21. Frey AD, Karg SR, Kallio PT. Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol J 2009; 7 : 33–48. [Google Scholar]
  22. Vézina LP, Faye L, Lerouge P, et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol J 2009; 7 : 442–55. [Google Scholar]
  23. Hellwig S, Drossard J, Twyman RM, et al. Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 2004; 22 : 1415–22. [Google Scholar]
  24. Cadoret JP, Bardor M, Lerouge P, et al. Microalgae as cell factories producing recombinant commercial proteins. Med Sci (Paris) 2008; 24 : 375–82. [Google Scholar]
  25. Cox KM, Sterling JD, Regan JT, et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 2006; 24 : 1591–7. [Google Scholar]
  26. Schuster M, Jost W, Mudde GC, et al. In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system. Biotechnol J 2007; 2 : 700–8. [Google Scholar]
  27. Houdebine LM. Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 2008. Epub Feb 1. [Google Scholar]
  28. Tang B, Yu S, Zheng M, et al. High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice. Transgenic Res 2008; 17 : 727–32. [Google Scholar]
  29. Raju TS, Briggs JB, Borge SM, et al. Species-specific variation in glycosylation of IgG : evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 2000; 10 : 477–86. [Google Scholar]
  30. Zhu L, van de Lavoir MC, Albanese J, et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol 2005; 23 : 1159–69. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.